What is Enliven Therapeutics's return on equity?

Enliven Therapeutics (ELVN) reported return on equity of -26.6% in Q1 2026.

How has Enliven Therapeutics's return on equity changed year-over-year?

Enliven Therapeutics's return on equity increased by 14.9% year-over-year, from -31.3% to -26.6%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Enliven Therapeutics ELVN Return on equity

Return on equity at other companies

Bristol-Myers SquibbBMY

38.8%+7.3pp

PfizerPFE

10.6%—

Relay Therapeutics, Inc.RLAY

-40%-4.3pp

Arcus BiosciencesRCUS

-70%+8.4pp

Intellia TherapeuticsNTLA

-56.3%-1.5pp

Nuvalent, Inc.NUVL

-41.2%+7.5pp

Other financials

Income statement

See full

Operating income-$27.8M+12.2%

Net income-$23.6M+17.2%

EPS (diluted)-$0.38+33.3%

Balance sheet

See full

Cash & equivalents$132.2M+30.0%

Total debt$302.0K-56.9%

Total equity$453.4M+57.3%

Total assets$464.9M+53.6%

Cash flow

See full

Operating cash flow-$19.3M+20.0%

CapEx--100%

Free cash flow-$19.3M+20.1%

Valuation

See full

Market cap$3.47B+143%

Enterprise value$3.34B+156%

Returns & leverage

See full

Debt / equity0×0.0×

Current ratio40.3×+19.3×

Where this comes from

Calculated from Enliven Therapeutics’s reported figures.

net income/total stockholders equity=-26.6%

Based on trailing twelve months.

The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enliven Therapeutics's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Enliven Therapeutics's return on equity?: Enliven Therapeutics (ELVN) reported return on equity of -26.6% in Q1 2026.
How has Enliven Therapeutics's return on equity changed year-over-year?: Enliven Therapeutics's return on equity increased by 14.9% year-over-year, from -31.3% to -26.6%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.